First Tracks Biotherapeutics, Inc. [TRAX] - equity issuance

First Tracks Biotherapeutics, Inc. is conducting a private placement of equity at a purchase price of $32.75 per share, expecting to raise approximately $200 million in gross proceeds, with the transaction set to close on October 19, 2026.

View source filing ↗